|
1
|
Piazuelo MB and Correa P: Gastric cancer:
Overview. Colomb Med (Cali). 44:192–201. 2013.PubMed/NCBI
|
|
2
|
Tong GX, Liang H, Chai J, Cheng J, Feng R,
Chen PL, Geng QQ, Shen XR and Wang DB: Association of risk of
gastric cancer and consumption of tobacco, alcohol and tea in the
Chinese population. Asian Pac J Cancer Prev. 15:8765–8774. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Shi J, Qu YP and Hou P: Pathogenetic
mechanisms in gastric cancer. World J Gastroenterol.
20:13804–13819. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Chen R, He Q, Cui J, Bian S and Chen L:
Lymph node metastasis in early gastric cancer. Chin Med J (Engl).
127:560–567. 2014.PubMed/NCBI
|
|
5
|
Yakirevich E and Resnick MB: Pathology of
gastric cancer and its precursor lesions. Gastroenterol Clin North
Am. 42:261–284. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Röcken C and Warneke V: Molecular
pathology of gastric cancer. Pathologe. 33 Suppl 2:S235–S240.
2012.(In German). View Article : Google Scholar
|
|
7
|
Cervantes A, Braun Rodríguez E, Fidalgo
Pérez A and Chirivella González I: Molecular biology of gastric
cancer. Clin Transl Oncol. 9:208–215. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Derrien T, Johnson R, Bussotti G, Tanzer
A, Djebali S, Tilgner H, Guernec G, Martin D, Merkel A, Knowles DG,
et al: The GENCODE v7 catalog of human long noncoding RNAs:
Analysis of their gene structure, evolution, and expression. Genome
Res. 22:1775–1789. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Djebali S, Davis CA, Merkel A, Dobin A,
Lassmann T, Mortazavi A, Tanzer A, Lagarde J, Lin W, Schlesinger F,
et al: Landscape of transcription in human cells. Nature.
489:101–108. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Fatima R, Akhade VS, Pal D and Rao SM:
Long noncoding RNAs in development and cancer: Potential biomarkers
and therapeutic targets. Mol Cell Ther. 3:52015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Shi X, Sun M, Liu H, Yao Y and Song Y:
Long non-coding RNAs: A new frontier in the study of human
diseases. Cancer Lett. 339:159–166. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhang F, Zhang L and Zhang C: Long
noncoding RNAs and tumorigenesis: Genetic associations, molecular
mechanisms, and therapeutic strategies. Tumour Biol. 37:163–175.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Li LJ, Zhu JL, Bao WS, Chen DK, Huang WW
and Weng ZL: Long noncoding RNA GHET1 promotes the development of
bladder cancer. Int J Clin Exp Pathol. 7:7196–7205. 2014.PubMed/NCBI
|
|
14
|
Yang F, Xue X, Zheng L, Bi J, Zhou Y, Zhi
K, Gu Y and Fang G: Long non-coding RNA GHET1 promotes gastric
carcinoma cell proliferation by increasing c-Myc mRNA stability.
FEBS J. 281:802–813. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Fang XY, Pan HF, Leng RX and Ye DQ: Long
noncoding RNAs: Novel insights into gastric cancer. Cancer Lett.
356:357–366. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhou X, Yin C, Dang Y, Ye F and Zhang G:
Identification of the long non-coding RNA H19 in plasma as a novel
biomarker for diagnosis of gastric cancer. Sci Rep. 5:115162015.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhu W, Ye L, Zhang J, Yu P, Wang H, Ye Z
and Tian J: PFK15, a small molecule inhibitor of PFKFB3, induces
cell cycle arrest, apoptosis and inhibits invasion in gastric
cancer. PLoS One. 11:e01637682016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Cidon EU, Ellis SG, Inam Y, Adeleke S,
Zarif S and Geldart T: Molecular targeted agents for gastric
cancer: A step forward towards personalized therapy. Cancers
(Basel). 5:64–91. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Polotskaia A, Xiao G, Reynoso K, Martin C,
Qiu W, Hendrickson RC and Bargonetti J: Proteome-wide analysis of
mutant p53 targets in breast cancer identifies new levels of
gain-of-function that influence PARP, PCNA, and MCM4. Proc Natl
Acad Sci USA. 112:E1220–E1229. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lv Q, Zhang J, Yi Y, Huang Y, Wang Y, Wang
Y and Zhang W: Proliferating cell nuclear antigen has an
association with prognosis and risk factors of cancer patients: A
systematic review. Mol Neurobiol. 53:6209–6217. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Massagué J: G1 cell-cycle control and
cancer. Nature. 432:298–306. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Sherr CJ: Mammalian G1 cyclins. Cell.
73:1059–1065. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Gérard C and Goldbeter A: The balance
between cell cycle arrest and cell proliferation: Control by the
extracellular matrix and by contact inhibition. Interface Focus.
4:201300752014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Tsihlias J, Kapusta L and Slingerland J:
The prognostic significance of altered cyclin-dependent kinase
inhibitors in human cancer. Annu Rev Med. 50:401–423. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Giacinti C and Giordano A: RB and cell
cycle progression. Oncogene. 25:5220–5227. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Dubravka D and Scott DW: Regulation of the
G1 phase of the mammalian cell cycle. Cell Res. 10:1–16. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Huang H, Liao W, Zhu X, Liu H and Cai L:
Knockdown of long noncoding RNA GHET1 inhibits cell activation of
gastric cancer. Biomed Pharmacother. 92:562–568. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Dang CV, Le A and Gao P: MYC-induced
cancer cell energy metabolism and therapeutic opportunities. Clin
Cancer Res. 15:6479–6483. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Chen BJ, Wu YL, Tanaka Y and Zhang W:
Small molecules targeting c-My oncogene: Promising anti-cancer
therapeutics. Int J Biol Sci. 10:1084–1096. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Doose G, Haake A, Bernhart SH, López C,
Duggimpudi S, Wojciech F, Bergmann AK, Borkhardt A, Burkhardt B,
Claviez A, et al: MINCR is a MYC-induced lncRNA able to modulate
MYC's transcriptional network in Burkitt lymphoma cells. Proc Natl
Acad Sci USA. 112:E5261–E5270. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Kim T, Cui R, Jeon YJ, Fadda P, Alder H
and Croce CM: MYC-repressed long noncoding RNAs antagonize
MYC-induced cell proliferation and cell cycle progression.
Oncotarget. 6:18780–18789. 2015.PubMed/NCBI
|
|
32
|
Winkle M, van den Berg A, Tayari M,
Sietzema J, Terpstra M, Kortman G, de Jong D, Visser L, Diepstra A,
Kok K and Kluiver J: Long noncoding RNAs as a novel component of
the Myc transcriptional network. FASEB J. 29:2338–2346. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Hung CL, Wang LY, Yu YL, Chen HW,
Srivastava S, Petrovics G and Kung HJ: A long noncoding RNA
connects c-Myc to tumor metabolism. Proc Natl Acad Sci USA.
111:18697–18702. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Kapinas K, Grandy R, Ghule P, Medina R,
Becker K, Pardee A, Zaidi SK, Lian J, Stein J, van Wijnen A and
Stein G: The abbreviated pluripotent cell cycle. J Cell Physiol.
228:9–20. 2013. View Article : Google Scholar : PubMed/NCBI
|
